News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Origen Therapeutics, Inc. Announces Change In Chief Financial Officer And Reports Naked Short Selling To SEC


10/6/2008 11:19:56 AM

BEIJING--(BUSINESS WIRE)--Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”), a leading technology-focused supplier of crop seeds in China, today announced that the company has appointed Yasheng Yang as the Acting Chief Financial Officer effective immediately. Yasheng Yang is replacing Veronica Chen, who is stepping down to pursue other opportunities.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES